Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Anti-cancer nuclear hormone receptor-targeting compounds

US Patent 12006314 · Granted Jun 11, 2024

Estimated economic value: $14,113,000

Assignee

Inventors

View full patent text on Google Patents →